Mike Ufer

ORCID: 0000-0002-6637-4406 · 1 paper in corpus

other 2025

Transfer of the Oral Gonadotropin-Releasing Hormone Receptor Antagonist Relugolix Into Breast Milk of Healthy Lactating Women

Pharmacology research & perspectives ·doi:10.1002/prp2.70067

Relugolix is an oral gonadotropin-releasing hormone receptor antagonist that suppresses sex steroid hormones and is approved as monotherapy for prostate cancer and as a fixed-dose combination with estradiol/norethindrone for the treatment o…